Form 4 for IDXX Idexx Laboratories
Accepted 2022-02-16 00:00:00 ET · period of report 2022-02-14 · accession 0001567619-22-004787 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-02-16 | 2022-02-14 | IDXX | Turner Kathy V | SVP | M - OptEx | $0.00 | +851 | 5,001 | +21% | $0 |
| D | 2022-02-16 | 2022-02-14 | IDXX | Turner Kathy V | SVP | F - Tax | $505.53 | -295 | 4,706 | -6% | -$149.1K |
| DM | 2022-02-16 | 2022-02-14 | IDXX | Turner Kathy V | SVP | A - Grant | — | +3,646 | 3,078 | New | — |
| DM | 2022-02-16 | 2022-02-14 | IDXX | Turner Kathy V | SVP | M - OptEx | — | -851 | 2,165 | -28% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-14 | M | A | 211 | $0.00 | 4,361.39 | D | — | — | (F1) Includes a total of 19 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on September 30, 2021 and December 31, 2021. |
| 2 | Common | Common Stock | 2022-02-14 | M | A | 210 | $0.00 | 4,571.39 | D | — | — | |
| 3 | Common | Common Stock | 2022-02-14 | M | A | 181 | $0.00 | 4,752.39 | D | — | — | |
| 4 | Common | Common Stock | 2022-02-14 | M | A | 162 | $0.00 | 4,914.39 | D | — | — | |
| 5 | Common | Common Stock | 2022-02-14 | M | A | 87 | $0.00 | 5,001.39 | D | — | — | |
| 6 | Common | Common Stock | 2022-02-14 | F | D | 295 | $505.53 | 4,706.39 | D | — | — | |
| 7 | Derivative | Incentive Stock Option (right-to-buy) | 2022-02-14 | A | A | 197 | — | 197 | D | $505.53 · — to 2032-02-13 | 197 Common Stock | (F11) Not applicable. (F4) Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on the fourth anniversary of the date of grant. |
| 8 | Derivative | Restricted Stock Unit | 2022-02-14 | M | D | 162 | — | 1,612 | D | — · — to — | 162 Common Stock | (F11) Not applicable. (F9) Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021. |
| 9 | Derivative | Restricted Stock Unit | 2022-02-14 | M | D | 181 | — | 1,774 | D | — · — to — | 181 Common Stock | (F11) Not applicable. (F8) Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020. |
| 10 | Derivative | Restricted Stock Unit | 2022-02-14 | M | D | 210 | — | 1,955 | D | — · — to — | 210 Common Stock | (F11) Not applicable. (F7) Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2019. |
| 11 | Derivative | Restricted Stock Unit | 2022-02-14 | A | A | 371 | — | 2,376 | D | — · — to — | 371 Common Stock | (F11) Not applicable. (F5) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023. |
| 12 | Derivative | Restricted Stock Unit | 2022-02-14 | M | D | 87 | — | 1,525 | D | — · — to — | 87 Common Stock | (F11) Not applicable. (F10) Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022. |
| 13 | Derivative | Non-Qualified Stock Option (right-to-buy) | 2022-02-14 | A | A | 3,078 | — | 3,078 | D | $505.53 · — to 2032-02-13 | 3,078 Common Stock | (F11) Not applicable. (F3) Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2023. |
| 14 | Derivative | Restricted Stock Unit | 2022-02-14 | M | D | 211 | — | 2,165 | D | — · — to — | 211 Common Stock | (F11) Not applicable. (F6) Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2018. |